Recent News

• 11.03.2026 - Iridex to Report Third Quarter 2026 Financial Results on November 17, 2026
• 10.12.2026 - Iridex Announces the Publication of Two-Year Independent Study Supporting Benefits of MicroPulse® Technology for Early to Advanced Glaucoma
• 10.05.2026 - Iridex Completes Relocation of Manufacturing Facility to San Jose, California
• 08.18.2026 - Iridex Reports Second Quarter 2026 Financial Results
• 08.04.2026 - Iridex to Report Second Quarter 2026 Financial Results on August 18, 2026
• 08.04.2026 - Iridex to Report Second Quarter 2026 Financial Results on August 18, 2026
• 07.20.2026 - Iridex Adds EndoProbe® Handpieces to EyeProGPO Product Offering
• 06.09.2026 - Iridex to Present at the Planet MicroCap Las Vegas 2026 Conference
• 05.19.2026 - Iridex Reports First Quarter 2026 Financial Results
• 05.05.2026 - Iridex to Report First Quarter 2026 Financial Results on May 19, 2026

Recent Filings

• 10.13.2026 - 4 Statement of changes in beneficial ownership of securities
• 10.07.2026 - 4 Statement of changes in beneficial ownership of securities
• 10.07.2026 - 4 Statement of changes in beneficial ownership of securities
• 10.07.2026 - 4 Statement of changes in beneficial ownership of securities
• 10.05.2026 - 4 Statement of changes in beneficial ownership of securities
• 09.16.2026 - 4 Statement of changes in beneficial ownership of securities
• 09.14.2026 - 4 Statement of changes in beneficial ownership of securities
• 09.10.2026 - 4 Statement of changes in beneficial ownership of securities
• 09.02.2026 - 8-K Current report
• 08.24.2026 - 4 Statement of changes in beneficial ownership of securities